同仁堂：公司高度重视智能化、数字化发展，拓宽同仁堂中医药知识图谱的查询与应用方式，积极探索赋能多元化、多角度、多层面的应用场景

互动易2025-08-01

有投资者向同仁堂提问，为评估公司价值，请说明 1. 是否在办公、研发、客户服务或业务流程中应用AI技术？ (a)是 (b)否 2. 若应用AI，是否曾使用： (a) ChatGPT (b) DeepSeek (c) 其他（请注明） 3. 在2025年初，是否将 ChatGPT 部分或全部替换为 DeepSeek？ (a)是(b)否(c)未用过ChatGPT (d) 试用deepseek后仍主要...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2556892455?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-01 18:03","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2556892455","market":"sh","top_or_hot":-1,"title":"同仁堂：公司高度重视智能化、数字化发展，拓宽同仁堂中医药知识图谱的查询与应用方式，积极探索赋能多元化、多角度、多层面的应用场景","media":"互动易","content":"<div>\n<p>有投资者向同仁堂提问， 为评估公司价值，请说明 1. 是否在办公、研发、客户服务或业务流程中应用AI技术？ (a)是 (b)否 2. 若应用AI，是否曾使用： (a) ChatGPT (b) DeepSeek (c) 其他（请注明） 3. 在2025年初，是否将 ChatGPT 部分或全部替换为 DeepSeek？ (a)是(b)否(c)未用过ChatGPT (d) 试用deepseek后仍主要...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801182506a6cd9a69&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>同仁堂：公司高度重视智能化、数字化发展，拓宽同仁堂中医药知识图谱的查询与应用方式，积极探索赋能多元化、多角度、多层面的应用场景</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n同仁堂：公司高度重视智能化、数字化发展，拓宽同仁堂中医药知识图谱的查询与应用方式，积极探索赋能多元化、多角度、多层面的应用场景\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-01 18:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801182506a6cd9a69&s=b><strong>互动易</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>有投资者向同仁堂提问， 为评估公司价值，请说明 1. 是否在办公、研发、客户服务或业务流程中应用AI技术？ (a)是 (b)否 2. 若应用AI，是否曾使用： (a) ChatGPT (b) DeepSeek (c) 其他（请注明） 3. 在2025年初，是否将 ChatGPT 部分或全部替换为 DeepSeek？ (a)是(b)否(c)未用过ChatGPT (d) 试用deepseek后仍主要...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801182506a6cd9a69&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801182506a6cd9a69&s=b","article_id":"2556892455","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801182506a6cd9a69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2556892455","pubTimestamp":1754042583,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"有投资者向同仁堂提问， 为评估公司价值，请说明 1. 是否在办公、研发、客户服务或业务流程中应用AI技术？公司高度重视智能化、数字化发展，拓宽同仁堂中医药知识图谱的查询与应用方式，积极探索赋能多元化、多角度、多层面的应用场景。同时公司提醒广大投资者，公司主营中成药的生产和销售，AI场景应用和实践未对公司经营业绩产生重大影响，敬请投资者理性投资并注意防范投资风险。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"561510":"中药ETF华泰柏瑞","562390":"中药50ETF","600085":"同仁堂","BK0028":"国家队","BK0183":"MSCI概念","BK0188":"融资融券","BK0012":"证金概念","BK0113":"养老产业","BK0086":"举牌","BK0196":"行业龙头","LU1688375341.USD":"贝莱德中国灵活股票基金","BK0239":"医药制造","BK0097":"医药电商"},"translate_title":"Tongrentang: The company attaches great importance to the development of intelligence and digitalization, broadens the query and application methods of Tongrentang's traditional Chinese medicine knowledge map, and actively explores and empowers diversified, multi-angle and multi-level application scenarios","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"561510":0.9,"562390":0.9,"600085":1},"content_text":"有投资者向同仁堂提问， 为评估公司价值，请说明 1. 是否在办公、研发、客户服务或业务流程中应用AI技术？ (a)是 (b)否 2. 若应用AI，是否曾使用： (a) ChatGPT (b) DeepSeek (c) 其他（请注明） 3. 在2025年初，是否将 ChatGPT 部分或全部替换为 DeepSeek？ (a)是(b)否(c)未用过ChatGPT (d) 试用deepseek后仍主要使用GPT公司回答表示，投资者您好！公司高度重视智能化、数字化发展，拓宽同仁堂中医药知识图谱的查询与应用方式，积极探索赋能多元化、多角度、多层面的应用场景。同时公司提醒广大投资者，公司主营中成药的生产和销售，AI场景应用和实践未对公司经营业绩产生重大影响，敬请投资者理性投资并注意防范投资风险。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2556892455","isCrawlerRequest":true}